{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T19:46:32Z","timestamp":1793303192641,"version":"4.5.0"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["P30EY001765"],"award-info":[{"award-number":["P30EY001765"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Drug Analysis Unit in the JHU Institute for Clinical and Translational Research"},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIH Roadmap for Medical Research"},{"name":"Burroughs Wellcome Preterm Birth Initiative","award":["1015020"],"award-info":[{"award-number":["1015020"]}]},{"name":"PhRMA Foundation Pre Doctoral Fellowship in Pharmacology\/Toxicology"},{"name":"NSF GRFP Fellowship"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.jconrel.2018.12.046","type":"journal-article","created":{"date-parts":[[2018,12,28]],"date-time":"2018-12-28T11:44:05Z","timestamp":1545997445000},"page":"74-86","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["Development of a mucoinert progesterone nanosuspension for safer and more effective prevention of preterm birth"],"prefix":"10.1016","volume":"295","author":[{"given":"Thuy","family":"Hoang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Zierden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhijit","family":"Date","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jairo","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9048-2717","authenticated-orcid":false,"given":"Sanjeev","family":"Gumber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Anders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Segars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Hanes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mala","family":"Mahendroo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura M.","family":"Ensign","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.jconrel.2018.12.046_bb0005","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/1742-4755-10-S1-S2","article-title":"Born too soon: the global epidemiology of 15 million preterm births","volume":"10","author":"Blencowe","year":"2013","journal-title":"Reprod. Health"},{"issue":"24","key":"10.1016\/j.jconrel.2018.12.046_bb0010","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1001\/jama.296.24.2907","article-title":"Groups take aim at us preterm birth rate","volume":"296","author":"Kuehn","year":"2006","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jconrel.2018.12.046_bb0015","doi-asserted-by":"crossref","first-page":"35","DOI":"10.5409\/wjcp.v5.i1.35","article-title":"Retinopathy of prematurity: past, present and future","volume":"5","author":"Shah","year":"2016","journal-title":"World J. Clin. Pediatr."},{"issue":"1","key":"10.1016\/j.jconrel.2018.12.046_bb0020","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1136\/archdischild-2015-309581","article-title":"Early and long-term outcome of infants born extremely preterm","volume":"102","author":"Johnson","year":"2017","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.jconrel.2018.12.046_bb0025","doi-asserted-by":"crossref","first-page":"584","DOI":"10.3389\/fimmu.2014.00584","article-title":"Strategies to prevent preterm birth","volume":"5","author":"Newnham","year":"2014","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.jconrel.2018.12.046_bb0030","first-page":"35","article-title":"Progesterone in normal and pathological pregnancy","volume":"27","author":"Di Renzo","year":"2016","journal-title":"Horm. Mol. Biol. Clin."},{"issue":"7","key":"10.1016\/j.jconrel.2018.12.046_bb0035","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1016\/j.fertnstert.2010.02.033","article-title":"Crinone vaginal gel is equally effective and better tolerated than intramuscular progesterone for luteal phase support in in vitro fertilization-embryo transfer cycles: a prospective randomized study","volume":"94","author":"Yanushpolsky","year":"2010","journal-title":"Fertil. Steril."},{"issue":"3","key":"10.1016\/j.jconrel.2018.12.046_bb0040","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/uog.15953","article-title":"Vaginal progesterone decreases preterm birth\u226434weeks of gestation in women with a singleton pregnancy and a short cervix: an updated meta-analysis including data from the OPPTIMUM study","volume":"48","author":"Romero","year":"2016","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.jconrel.2018.12.046_bb0045","first-page":"60","article-title":"Progesterone supplementation and the prevention of preterm birth","volume":"4","author":"Norwitz","year":"2011","journal-title":"Rev. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.jconrel.2018.12.046_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.fertnstert.2004.01.025","article-title":"Why consider vaginal drug administration","volume":"82","author":"Alexander","year":"2004","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jconrel.2018.12.046_bb0055","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1749-6632.1997.tb48550.x","article-title":"The first uterine pass effect","volume":"828","author":"De Ziegler","year":"1997","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"1","key":"10.1016\/j.jconrel.2018.12.046_bb0060","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/uog.9017","article-title":"Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial","volume":"38","author":"Hassan","year":"2011","journal-title":"Ultrasound Obstetr. Gynecol."},{"issue":"9680","key":"10.1016\/j.jconrel.2018.12.046_bb0065","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1016\/S0140-6736(09)60947-8","article-title":"Progesterone for the prevention of preterm birth in twin pregnancy (STOPPIT): a randomised, double-blind, placebo-controlled study and meta-analysis","volume":"373","author":"Norman","year":"2009","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jconrel.2018.12.046_bb0070","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/uog.5158","article-title":"Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial","volume":"30","author":"O'Brien","year":"2007","journal-title":"Ultrasound Obstetr. Gynecol."},{"key":"10.1016\/j.jconrel.2018.12.046_bb0075","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2147\/IJWH.S28944","article-title":"Vaginal progesterone in risk reduction of preterm birth in women with short cervix in the midtrimester of pregnancy","volume":"4","author":"Khandelwal","year":"2012","journal-title":"Int. J. Womens Health"},{"issue":"11","key":"10.1016\/j.jconrel.2018.12.046_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0048328","article-title":"Is wetter better? An evaluation of over-the-counter personal lubricants for safety and anti-HIV-1 activity","volume":"7","author":"Dezzutti","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2018.12.046_bb0085","first-page":"139","article-title":"Leakage of three commercial vaginal gels in women","volume":"68","author":"Zeitlin","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.jconrel.2018.12.046_bb0090","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1186\/1471-2334-10-331","article-title":"Microbicide excipients can greatly increase susceptibility to genital herpes transmission in the mouse","volume":"10","author":"Moench","year":"2010","journal-title":"BMC Infect. Dis."},{"issue":"28","key":"10.1016\/j.jconrel.2018.12.046_bb0095","doi-asserted-by":"crossref","first-page":"6922","DOI":"10.1016\/j.biomaterials.2013.05.039","article-title":"Enhanced vaginal drug delivery through the use of hypotonic formulations that induce fluid uptake","volume":"34","author":"Ensign","year":"2013","journal-title":"Biomaterials"},{"issue":"138","key":"10.1016\/j.jconrel.2018.12.046_bb0100","doi-asserted-by":"crossref","first-page":"138ra179","DOI":"10.1126\/scitranslmed.3003453","article-title":"Mucus-penetrating nanoparticles for vaginal drug delivery protect against herpes simplex virus","volume":"4","author":"Ensign","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2018.12.046_bb0105","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.biomaterials.2018.09.005","article-title":"Mucus-penetrating budesonide nanosuspension enema for local treatment of inflammatory bowel disease","volume":"185","author":"Date","year":"2018","journal-title":"Biomaterials"},{"issue":"21","key":"10.1016\/j.jconrel.2018.12.046_bb0110","doi-asserted-by":"crossref","first-page":"6592","DOI":"10.1158\/1078-0432.CCR-17-1082","article-title":"Preclinical evaluation of intravesical cisplatin nanoparticles for non-muscle-invasive bladder cancer","volume":"23","author":"Kates","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"28","key":"10.1016\/j.jconrel.2018.12.046_bb0115","doi-asserted-by":"crossref","first-page":"8720","DOI":"10.1073\/pnas.1502281112","article-title":"Highly compacted biodegradable DNA nanoparticles capable of overcoming the mucus barrier for inhaled lung gene therapy","volume":"112","author":"Mastorakos","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.jconrel.2018.12.046_bb0120","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1601556","article-title":"Nanoparticles that do not adhere to mucus provide uniform and long-lasting drug delivery to airways following inhalation","volume":"3","author":"Schneider","year":"2017","journal-title":"Sci. Adv."},{"issue":"3","key":"10.1016\/j.jconrel.2018.12.046_bb0125","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1167\/tvst.4.3.11","article-title":"Topical ocular drug delivery to the back of the eye by mucus-penetrating particles","volume":"4","author":"Schopf","year":"2015","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.jconrel.2018.12.046_bb0130","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"21","key":"10.1016\/j.jconrel.2018.12.046_bb0135","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1002\/adhm.201600599","article-title":"Mucus-penetrating nanosuspensions for enhanced delivery of poorly soluble drugs to mucosal surfaces","volume":"5","author":"Yu","year":"2016","journal-title":"Adv. Healthc. Mater."},{"issue":"149","key":"10.1016\/j.jconrel.2018.12.046_bb0140","doi-asserted-by":"crossref","first-page":"149ra119","DOI":"10.1126\/scitranslmed.3003594","article-title":"A dense poly(ethylene glycol) coating improves penetration of large polymeric nanoparticles within brain tissue","volume":"4","author":"Nance","year":"2012","journal-title":"Sci. Transl. Med."},{"issue":"2","key":"10.1016\/j.jconrel.2018.12.046_bb0145","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/00007435-200302000-00002","article-title":"A self-sampling method to obtain large volumes of undiluted cervicovaginal secretions","volume":"30","author":"Boskey","year":"2003","journal-title":"Sex. Transm. Dis."},{"issue":"1","key":"10.1016\/j.jconrel.2018.12.046_bb0150","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1582-4934.2012.01650.x","article-title":"Myometrial immune cells contribute to term parturition, preterm labour and post-partum involution in mice","volume":"17","author":"Shynlova","year":"2013","journal-title":"J. Cell. Mol. Med."},{"issue":"3","key":"10.1016\/j.jconrel.2018.12.046_bb0155","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/BF01062139","article-title":"Testing for the equality of area under the curves when using destructive measurement techniques","volume":"16","author":"Bailer","year":"1988","journal-title":"J. Pharmacokinet. Biopharm."},{"issue":"2","key":"10.1016\/j.jconrel.2018.12.046_bb0160","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1073\/pnas.0911748107","article-title":"Nanoparticles reveal that human cervicovaginal mucus is riddled with pores larger than viruses","volume":"107","author":"Lai","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"12","key":"10.1016\/j.jconrel.2018.12.046_bb0165","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1021\/bm401356q","article-title":"The microstructure and bulk rheology of human cervicovaginal mucus are remarkably resistant to changes in pH","volume":"14","author":"Wang","year":"2013","journal-title":"Biomacromolecules"},{"issue":"2","key":"10.1016\/j.jconrel.2018.12.046_bb0170","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"A simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair","year":"2016","journal-title":"J. Basic Clin. Pharm."},{"issue":"9","key":"10.1016\/j.jconrel.2018.12.046_bb0175","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/pch\/16.9.535","article-title":"Pharmacokinetics 101","volume":"16","author":"Ito","year":"2011","journal-title":"Paediatr. Child Health"},{"issue":"5","key":"10.1016\/j.jconrel.2018.12.046_bb0180","doi-asserted-by":"crossref","first-page":"455 e451","DOI":"10.1016\/j.ajog.2010.03.025","article-title":"Pharmacologic actions of progestins to inhibit cervical ripening and prevent delivery depend on their properties, the route of administration, and the vehicle","volume":"202","author":"Kuon","year":"2010","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"5","key":"10.1016\/j.jconrel.2018.12.046_bb0185","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1095\/biolreprod55.5.992","article-title":"Induction of preterm birth in mice by RU486","volume":"55","author":"Dudley","year":"1996","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.jconrel.2018.12.046_bb0190","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/353297","article-title":"Progesterone interactions with the cervix: translational implications for term and preterm birth","volume":"2011","author":"Larsen","year":"2011","journal-title":"Infect. Dis. Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.jconrel.2018.12.046_bb0195","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1055\/s-0037-1599091","article-title":"Distinct roles of cervical epithelia and stroma in pregnancy and parturition","volume":"35","author":"Nallasamy","year":"2017","journal-title":"Semin. Reprod. Med."},{"issue":"3","key":"10.1016\/j.jconrel.2018.12.046_bb0200","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1210\/en.2010-1105","article-title":"The molecular mechanisms of cervical ripening differ between term and preterm birth","volume":"152","author":"Holt","year":"2011","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.jconrel.2018.12.046_bb0205","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1055\/s-2006-956777","article-title":"Dynamics of cervical remodeling during pregnancy and parturition: mechanisms and current concepts","volume":"25","author":"Word","year":"2007","journal-title":"Semin. Reprod. Med."},{"issue":"4","key":"10.1016\/j.jconrel.2018.12.046_bb0210","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/uog.2773","article-title":"Prediction of patient-specific risk of early preterm delivery using maternal history and sonographic measurement of cervical length: a population-based prospective study","volume":"27","author":"To MS","year":"2006","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"6","key":"10.1016\/j.jconrel.2018.12.046_bb0215","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1067\/mob.2000.106851","article-title":"Patients with an ultrasonographic cervical length \u226415 mm have nearly a 50% risk of early spontaneous preterm delivery","volume":"182","author":"Hassan","year":"2000","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"9","key":"10.1016\/j.jconrel.2018.12.046_bb0220","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJM199602293340904","article-title":"The length of the cervix and the risk of spontaneous premature delivery","volume":"334","author":"Iams","year":"1996","journal-title":"N. Engl. J. Med."},{"issue":"10033","key":"10.1016\/j.jconrel.2018.12.046_bb0225","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(16)00350-0","article-title":"Vaginal progesterone prophylaxis for preterm birth (the OPPTIMUM study): a multicentre, randomised, double-blind trial","volume":"387","author":"Norman","year":"2016","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jconrel.2018.12.046_bb0230","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ajog.2017.11.576","article-title":"Vaginal progesterone for preventing preterm birth and adverse perinatal outcomes in singleton gestations with a short cervix: a meta-analysis of individual patient data","volume":"218","author":"Romero","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jconrel.2018.12.046_bb0235","unstructured":"Watson Pharma I (Revised August 2013) Crinone 4% and Crinone 8 (https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2013\/020701s026lbl.pdf)."},{"issue":"9","key":"10.1016\/j.jconrel.2018.12.046_bb0240","first-page":"512","article-title":"The nanomedicine revolution: part 1: emerging concepts","volume":"37","author":"Ventola","year":"2012","journal-title":"PT"},{"issue":"2","key":"10.1016\/j.jconrel.2018.12.046_bb0245","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1177\/1933719108329095","article-title":"Inflammation and pregnancy","volume":"16","author":"Challis","year":"2009","journal-title":"Reprod. Sci."},{"issue":"9","key":"10.1016\/j.jconrel.2018.12.046_bb0250","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/molehr\/7.9.875","article-title":"Interactions between progesterone receptor isoforms in myometrial cells in human labour","volume":"7","author":"Pieber","year":"2001","journal-title":"Mol. Hum. Reprod."},{"issue":"10","key":"10.1016\/j.jconrel.2018.12.046_bb0255","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1056\/NEJMcibr1100071","article-title":"How does progesterone relax the uterus in pregnancy?","volume":"364","author":"Zakar","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2018.12.046_bb0260","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11565","article-title":"Molecular evidence of functional progesterone withdrawal in human myometrium","volume":"7","author":"Nadeem","year":"2016","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.jconrel.2018.12.046_bb0265","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/S0002-9378(87)80315-0","article-title":"Effects of the antiprogesterone RU 486 on preterm birth in the rat","volume":"157","author":"Garfield","year":"1987","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"6","key":"10.1016\/j.jconrel.2018.12.046_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2015.08.010","article-title":"Vaginal progesterone, but not 17 alpha-hydroxyprogesterone caproate, has antiinflammatory effects at the murine maternal-fetal interface","volume":"213","author":"Furcron","year":"2015","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.jconrel.2018.12.046_bb0275","doi-asserted-by":"crossref","first-page":"223 e221","DOI":"10.1016\/j.ajog.2013.01.020","article-title":"Prevention of preterm birth by progestational agents: what are the molecular mechanisms?","volume":"208","author":"Nold","year":"2013","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jconrel.2018.12.046_bb0280","series-title":"Clinical Pharmacology and Biopharmaceutics Review for Mifepristone Tablets, 200 mg. in Application number 20-687","author":"Anonymous","year":"1996"},{"issue":"6","key":"10.1016\/j.jconrel.2018.12.046_bb0285","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1097\/AOG.0b013e31821c6fb1","article-title":"Deus ex Makena?","volume":"117","author":"Silver","year":"2011","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.jconrel.2018.12.046_bb0290","first-page":"1","article-title":"The association of different progesterone preparations with preterm birth prevention","author":"Krispin","year":"2018","journal-title":"J. Matern. Fetal Neonatal Med."},{"issue":"10\u221211","key":"10.1016\/j.jconrel.2018.12.046_bb0295","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0039-128X(00)00121-5","article-title":"Pharmacokinetics of the progesterone-containing vaginal tablet and its use in assisted reproduction","volume":"65","author":"Levy","year":"2000","journal-title":"Steroids"},{"issue":"2","key":"10.1016\/j.jconrel.2018.12.046_bb0300","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/humupd\/6.2.139","article-title":"Comparison between different routes of progesterone administration as luteal phase support in infertility treatments","volume":"6","author":"Tavaniotou","year":"2000","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.jconrel.2018.12.046_bb0305","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2017.00212","article-title":"Pharmacokinetic properties of three forms of vaginal progesterone administered in either single or multiple dose regimen in healthy post-menopausal Chinese women","volume":"8","author":"Wu","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jconrel.2018.12.046_bb0310","author":"Columbia Research Laboratories I"},{"issue":"8","key":"10.1016\/j.jconrel.2018.12.046_bb0315","first-page":"855","article-title":"A double-peak phenomenon in the pharmacokinetics of alprazolam after oral administration","volume":"27","author":"Wang","year":"1999","journal-title":"Drug Metab. Dispos."},{"issue":"1","key":"10.1016\/j.jconrel.2018.12.046_bb0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/rep.0.1240001","article-title":"Prostaglandins and mechanisms of preterm birth","volume":"124","author":"Challis","year":"2002","journal-title":"Reproduction"},{"key":"10.1016\/j.jconrel.2018.12.046_bb0325","first-page":"73","article-title":"The role of progesterone in prevention of preterm birth","volume":"1","author":"Dodd","year":"2010","journal-title":"Int. J. Womens Health"},{"issue":"5","key":"10.1016\/j.jconrel.2018.12.046_bb0330","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/humupd\/4.5.673","article-title":"Control and assessment of the uterus and cervix during pregnancy and labour","volume":"4","author":"Garfield","year":"1998","journal-title":"Hum. Reprod. Update"},{"issue":"1","key":"10.1016\/j.jconrel.2018.12.046_bb0335","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12916-016-0632-4","article-title":"Modeling hormonal and inflammatory contributions to preterm and term labor using uterine temporal transcriptomics","volume":"14","author":"Migale","year":"2016","journal-title":"BMC Med."},{"issue":"2","key":"10.1016\/j.jconrel.2018.12.046_bb0340","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s10461-017-1811-9","article-title":"Acceptability of and adherence to an antiretroviral-based vaginal microbicide among pregnant women in the United States","volume":"22","author":"Montgomery","year":"2018","journal-title":"AIDS Behav."},{"issue":"3","key":"10.1016\/j.jconrel.2018.12.046_bb0345","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150896","article-title":"Drivers of vaginal drug delivery system acceptability from internet-based conjoint analysis","volume":"11","author":"Primrose","year":"2016","journal-title":"PLoS One"},{"issue":"Suppl A","key":"10.1016\/j.jconrel.2018.12.046_bb0350","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1053\/plac.2002.0948","article-title":"Cytokines, prostaglandins and parturition\u2014a review","volume":"24","author":"Keelan","year":"2003","journal-title":"Placenta"},{"issue":"8","key":"10.1016\/j.jconrel.2018.12.046_bb0355","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.1210\/en.2010-0063","article-title":"Interleukin-6 is an essential determinant of on-time parturition in the mouse","volume":"151","author":"Robertson","year":"2010","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.jconrel.2018.12.046_bb0360","doi-asserted-by":"crossref","first-page":"R525","DOI":"10.1152\/ajpregu.00153.2009","article-title":"Are animal models relevant to key aspects of human parturition?","volume":"297","author":"Mitchell","year":"2009","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"4","key":"10.1016\/j.jconrel.2018.12.046_bb0365","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1600-0897.2012.01110.x","article-title":"Models of fetal brain injury, intrauterine inflammation, and preterm birth","volume":"67","author":"Burd","year":"2012","journal-title":"Am. J. Reprod. Immunol."},{"issue":"9","key":"10.1016\/j.jconrel.2018.12.046_bb0370","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1002\/jnr.22368","article-title":"Inflammation-induced preterm birth alters neuronal morphology in the mouse fetal brain","volume":"88","author":"Burd","year":"2010","journal-title":"J. Neurosci. Res."},{"issue":"1","key":"10.1016\/j.jconrel.2018.12.046_bb0375","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1210\/en.2013-1304","article-title":"Prostaglandins are essential for cervical ripening in LPS-mediated preterm birth but not term or antiprogestin-driven preterm ripening","volume":"155","author":"Timmons","year":"2014","journal-title":"Endocrinology"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836591830751X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836591830751X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T01:40:32Z","timestamp":1565228432000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016836591830751X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":75,"alternative-id":["S016836591830751X"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2018.12.046","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a mucoinert progesterone nanosuspension for safer and more effective prevention of preterm birth","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2018.12.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}